Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 19 Mar 2022 - 25 Mar 2022
DATE PUBLISHED: 2022 Mar 18
JOURNAL:Cephalalgia
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/35301859?dopt=Abstract
To determine whether glibenclamide, a non-selective adenosine 5'-triphosphate-sensitive K (K) channel blocker, attenuates pituitary adenylate cyclase-activating polypeptide-38 (PACAP38)-induced headache and vascular changes in healthy volunteers.